• 1. An investigation on the interaction modes of a single-strand DNA aptamer and RBP4 protein: a molecular dynamic simulations approach?
  Raheleh Torabi,Hedayatollah Ghourchian,Massoud Amanlou Org. Biomol. Chem., 2016,14, 8141-8153
• 2. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 3. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 4. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 5. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592

• Solvents and Organic Chemicals Organic Compounds Organohalogen compounds Aryl halides Aryl chlorides

Introduction to 5-chloro-3-(chloromethyl)-1-methyl-1H-pyrazole (CAS No. 524740-33-8)

5-chloro-3-(chloromethyl)-1-methyl-1H-pyrazole, identified by the CAS number 524740-33-8, is a significant compound in the field of pharmaceutical and chemical research. This heterocyclic compound features a pyrazole core substituted with chloro, chloromethyl, and methyl groups, making it a versatile intermediate for various synthetic applications. The unique structural attributes of this molecule contribute to its utility in the development of bioactive molecules, particularly in medicinal chemistry.

The pyrazole scaffold is well-documented for its broad spectrum of biological activities, including antimicrobial, anti-inflammatory, and anticancer properties. The presence of the chloro and chloromethyl substituents in 5-chloro-3-(chloromethyl)-1-methyl-1H-pyrazole enhances its reactivity, enabling further functionalization through nucleophilic substitution reactions. This characteristic makes it a valuable building block for designing novel therapeutic agents.

In recent years, there has been growing interest in the synthesis and application of pyrazole derivatives due to their potential pharmacological effects. Studies have demonstrated that compounds incorporating the pyrazole ring can modulate various biological pathways, making them attractive candidates for drug discovery. The 5-chloro-3-(chloromethyl)-1-methyl-1H-pyrazole structure provides a framework for exploring such interactions, particularly in the context of enzyme inhibition and receptor binding.

One of the most compelling aspects of 5-chloro-3-(chloromethyl)-1-methyl-1H-pyrazole is its role as a precursor in the synthesis of more complex molecules. Researchers have leveraged its reactive sites to develop derivatives with enhanced potency and selectivity. For instance, the chloromethyl group can be readily converted into other functional moieties such as alcohols or amines, facilitating the creation of diverse chemical libraries.

The pharmaceutical industry has been particularly keen on exploring pyrazole derivatives for their therapeutic potential. Preclinical studies have shown that certain modifications of the pyrazole core can lead to compounds with significant biological activity. The incorporation of electronegative atoms like chlorine enhances electronic properties, influencing both solubility and metabolic stability. These factors are critical in determining the pharmacokinetic profile of drug candidates.

Moreover, advances in computational chemistry have enabled more efficient virtual screening and design of pyrazole-based compounds. Molecular modeling techniques allow researchers to predict interactions between 5-chloro-3-(chloromethyl)-1-methyl-1H-pyrazole derivatives and biological targets with high precision. This approach accelerates the drug discovery process by identifying promising candidates before experimental validation.

The synthetic pathways for 5-chloro-3-(chloromethyl)-1-methyl-1H-pyrazole have also seen considerable innovation. Modern synthetic methods focus on improving yield, purity, and scalability while minimizing environmental impact. Catalytic processes and green chemistry principles are increasingly being applied to develop sustainable routes for producing this compound.

In conclusion, 5-chloro-3-(chloromethyl)-1-methyl-1H-pyrazole (CAS No. 524740-33-8) represents a crucial intermediate in pharmaceutical chemistry. Its structural features and reactivity make it an indispensable tool for designing novel bioactive molecules. As research continues to uncover new applications for pyrazole derivatives, compounds like this are poised to play a pivotal role in the development of next-generation therapeutics.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)